Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 2 OF 11 | DISPLAYING 16 - 30 OF 160 RESULTS

    Sugio T. et. al., Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS, 10.1182/bloodadvances.2018018754, Blood Adv., Sep 07, 2018

    Moyes K.W. et. al., Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma., 10.1080/2162402X.2018.1507668., Oncoimmunology, Aug 27, 2018

    Jiang P. et. al., Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response, https://doi.org/10.1038/s41591-018-0136-1, Nature Med., Aug 20, 2018

    Chakravarthy A. et. al., Pan-cancer deconvolution of tumour composition using DNA methylation, https://doi.org/10.1038/s41467-018-05570-1, Nature Commun., Aug 13, 2018

    Kim S-S. et. al., Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor, 10.1080/2162402X.2018.1484982, Oncoimmunology, Aug 01, 2018

    Polumuri S.K. et. al., Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities, https://doi.org/10.1038/s41598-018-29850-4, Sci. Reports, Jul 31, 2018

    Owens G.L. et. al., Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells, 10.1007/s00262-018-2211-3, Cancer Immunol. Immunother., Jul 23, 2018

    Pollari M. et. al., PD-L1+ tumor-associated macrophages and PD-1+ tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma, 10.3324/haematol.2018.197194, Haematalogica, Jul 19, 2018

    Nguyen A. et. al., HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants, https://doi.org/10.1016/j.celrep.2018.06.040, Cell Reports, Jul 17, 2018

    Oseledchyk A. et. al., Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus, 10.18632/oncotarget.25614, Oncotarget, Jun 19, 2018

    Chihara N. et. al., Induction and transcriptional regulation of the co-inhibitory gene module in T cells, https://doi.org/10.1038/s41586-018-0206-z, Nature, Jun 13, 2018

    Yeong Y. et. al., 2018 High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer, https://doi.org/10.3389/fimmu.2018.01209 , Frontiers in Immunol., May 30, 2018

    Chen M. et. al., 2018 JAK2 and PD-L1 amplification enhance the dynamic expression of PD-L1 in triple negative breast cancer, https://doi.org/10.1016/j.clbc.2018.05.006, Clin. Breast Can., May 26, 2018

    Gullo I. et. al., 2018 New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression., 10.1007/s10120-018-0836-8, Gastric Cancer, May 19, 2018

    Ignatiadis M. et. al., 2018 Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy., 10.1093/jnci/djy076., JNCI, May 18, 2018